List of insiders holdings for BELLICUM PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| BAKER BROS. ADVISORS LP BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC 10% Owner | 2023-11-24 13:43:27 | 2,365,472 0 | 2,365,472 | Form 13D |
| McGuyer Investments Ltd. 10% Owner | 2014-12-23 16:29:31 | 2,260,133 0 | 2,260,133 | Form 4 |
| Remeditex Ventures LLC 10% Owner | 2014-12-23 16:25:28 | 1,851,166 0 | 1,851,166 | Form 4 |
| Fair Richard A. President and CEO | 2022-08-16 17:04:29 | 400,000 0 | 400,000 | Form 4 |
| Scripture Charity Chief Development Officer | 2022-08-16 17:04:47 | 250,000 0 | 250,000 | Form 4 |
| Stonehouse Jon P Director | 2023-01-05 13:11:55 | 204,086 0 | 204,086 | Form 4 |
| Huber Reid M Director | 2023-01-20 14:24:51 | 146,951 0 | 146,951 | Form 4/A |
| DAVIS STEPHEN Director | 2023-01-05 13:12:31 | 136,854 0 | 136,854 | Form 4 |
| Klimovsky Judith V Director | 2023-01-05 13:04:50 | 110,098 0 | 110,098 | Form 4 |
| Daly James M Director | 2023-01-05 13:12:48 | 109,873 0 | 109,873 | Form 4 |
| Farrell Thomas J. President and CEO | 2017-01-05 19:14:53 | 75,250 0 | 75,250 | Form 4 |
| Musso Alan A CFO and Treasurer | 2018-07-05 16:03:57 | 52,500 0 | 52,500 | Form 4 |
| Strauss David Eric Sr Director, Corp Controller | 2020-12-16 13:55:31 | 35,000 0 | 35,000 | Form 4 |
| BROWN JAMES F Director | 2022-01-06 09:49:40 | 28,384 0 | 28,384 | Form 4 |
| Moseley Annemarie COO/EVP Clinical Development | 2017-01-05 19:15:43 | 28,000 0 | 28,000 | Form 4 |
| Grossman William Sr. VP, Chief Medical Officer | 2019-02-07 16:02:03 | 26,874 0 | 26,874 | Form 4 |
| HARRIGAN EDMUND Director | 2019-06-14 16:05:25 | 25,000 0 | 25,000 | Form 4 |
| Smith Alan K. EVP, Technical Operations | 2020-04-09 14:41:41 | 22,307 0 | 22,307 | Form 4 |
| Mokari Atabak Chief Financial Officer | 2020-04-09 14:42:58 | 21,792 0 | 21,792 | Form 4 |
| Senesac Joseph VP of Manufacturing | 2015-02-26 18:33:20 | 20,000 0 | 20,000 | Form 4 |
| Foster Aaron E. Sr VP, Head of Research | 2020-04-09 14:44:11 | 19,517 0 | 19,517 | Form 4 |
| Hoang Peter L. Sr. VP of Bus. Development | 2017-01-05 19:18:03 | 17,500 0 | 17,500 | Form 4 |
| Spencer David M. Chief Technology Officer | 2019-02-05 16:10:56 | 15,000 0 | 15,000 | Form 4 |
| Naeve Gregory S. Chief Business Officer | 2019-08-23 16:04:17 | 13,746 0 | 13,746 | Form 4 |
| Woodard Jr Joseph Paul SVP Clinical & Medical Affairs | 2019-11-14 17:11:12 | 12,967 0 | 12,967 | Form 4 |
| McGuyer Frank B. Director | 2018-06-18 16:33:28 | 10,000 0 | 10,000 | Form 4 |
| Slawin Kevin M. Director | 2017-06-15 16:43:12 | 10,000 0 | 10,000 | Form 4 |
| Williams Rosemary Y. VP, Finance & PAO | 2020-01-06 17:15:26 | 9,099 0 | 9,099 | Form 4 |
| Moseley Ken Sr. VP and General Counsel | 2018-01-05 16:03:18 | 6,152 2,193 | 8,345 | Form 4 |
| Ward Shane Sr VP and Chief Legal SO | 2020-06-02 12:25:24 | 1,879 0 | 1,879 | Form 4 |
| Grass Charles S. Principal Accounting Officer | 2021-05-17 17:34:14 | 0 0 | 0 | Form 3 |